Call to Schedule Free Consultation at Over 80 Centers Worldwide!

(844) GET-STEM

How Do Mesenchymal Stem Cells Affect the Immune System?

Written by Dr. David Greene, MD, PhD, MBA on July 16, 2026

Table of Contents

If you’ve spent any time researching regenerative medicine, you’ve likely come across bold claims that mesenchymal stem cells (MSCs) “boost” the immune system. It’s an appealing idea, especially for people exploring anti-aging therapies or looking for ways to support their body’s natural defenses. But the actual relationship between MSCs and the immune system is more nuanced — and understanding that nuance matters if you’re weighing your options as a patient.

This article breaks down what mesenchymal stem cells actually do when they interact with immune cells, based on peer-reviewed research rather than simplified marketing language. We’ll look at natural killer (NK) cells, T cells, inflammatory cytokines, and the concept of “inflammaging,” and we’ll be transparent about where the evidence is strong, where it’s mixed, and where common claims outpace the data.

What Are Mesenchymal Stem Cells?

Mesenchymal stem cells are multipotent adult stem cells found in tissues such as bone marrow, adipose (fat) tissue, umbilical cord tissue, and dental pulp. They’re best known for their ability to differentiate into bone, cartilage, and fat cells, but a large and growing body of research has focused on a different property: their capacity to interact with — and regulate — the immune system, positioning mesenchymal stem cells as a broader therapeutic strategy beyond simple tissue repair.

This immune-regulating property is why MSCs are being studied and used in contexts ranging from graft-versus-host disease and autoimmune conditions to, more recently, general wellness and anti-aging protocols.

MSCs and the Immune System: Modulation, Not Simple "Boosting"

The most accurate description of what MSCs do to the immune system is that they modulate it. Immunomodulation means an intervention can push immune activity up or down depending on the surrounding biological context — it is not synonymous with uniformly strengthening immune defenses. A closer look at how stem cells affect the immune system makes clear why “boost” is the wrong word for this relationship.

This distinction matters because much of the popular framing around MSCs and immunity describes a one-directional “boost.” The research paints a more layered picture, which we’ll walk through cell type by cell type below.

MSCs and Natural Killer (NK) Cells

Natural killer cells are part of the innate immune system. They patrol the body and are capable of recognizing and destroying virus-infected cells, foreign pathogens, and abnormal or cancerous cells without needing prior exposure to a specific threat.

Popular claims suggest MSCs straightforwardly enhance NK cell activity. The evidence is actually mixed and depends heavily on conditions such as the ratio of MSCs to NK cells, the tissue source of the MSCs, and how the NK cells were activated beforehand. Multiple peer-reviewed studies have found that MSCs commonly inhibit NK cell proliferation and reduce NK cell cytotoxicity, largely through the release of factors such as indoleamine 2,3-dioxygenase (IDO) and prostaglandin E2 (PGE2). Other, more limited research has shown that under specific inflammatory conditions, MSCs can support certain aspects of NK cell function.

Patient takeaway: The relationship between MSCs and NK cells is genuinely mixed in the scientific literature. Claims that MSCs simply “enhance” NK cell activity oversimplify a more complex, context-dependent interaction — and in most experimental settings, the opposite (suppression) has been more consistently observed.

MSCs and T Cells

T cells are central to adaptive immunity and to many inflammatory and autoimmune processes. Here, the research is considerably more consistent: MSCs broadly suppress T cell activation and proliferation. This is one of the best-established immunological properties of MSCs and is the basis for their use in transplant medicine and autoimmune disease research, where dampening an overactive T cell response is the therapeutic goal.

MSCs also promote the expansion of regulatory T cells (Tregs) — a specialized T cell subset that helps keep the rest of the immune system in check, preventing excessive inflammation and the immune dysregulation that can lead to the immune system attacking itself. This Treg-supportive effect is one of the more consistently reproduced findings across independent research groups.

Patient takeaway: Describing T cell inhibition and Treg expansion as an immune “boost” is a mischaracterization. What’s happening is closer to immune rebalancing — reducing excessive or misdirected immune activity, not increasing the body’s raw offensive capacity against pathogens.

MSCs and Inflammatory Cytokines

This is where the strongest and most consistent evidence exists. MSCs are well documented to reduce pro-inflammatory cytokine levels while increasing anti-inflammatory signaling molecules such as IL-10. This anti-inflammatory effect is a core, reproducible feature of MSC biology across many independent studies and clinical contexts.

Inflammaging: Why Chronic Inflammation Matters as We Age

“Inflammaging” is a term used in gerontology research to describe the chronic, low-grade, systemic inflammation that tends to increase with age, even in the absence of acute infection. This persistent inflammatory state is associated with a higher risk of several age-related chronic diseases and is an active area of research into why we age and how we can mitigate the effects of getting older.

Because MSCs have a well-supported ability to reduce pro-inflammatory cytokine levels and support regulatory immune populations, their most defensible connection to healthy aging is through addressing this chronic inflammatory burden — not through a generalized enhancement of pathogen-fighting ability. Lifestyle factors such as diet, physical activity, sleep, and stress management remain foundational tools for managing inflammaging, and any cellular therapy should be understood as a potential complement to those factors rather than a replacement for them.

Putting It Together: A More Accurate Picture

Immune Component

Common Marketing Claim

What Research Actually Shows

Natural killer (NK) cells

MSCs boost NK cell activity

Mixed evidence; suppression of NK proliferation/cytotoxicity is reported more consistently than enhancement

T cells

MSCs boost T cell-driven immunity

MSCs generally suppress T cell proliferation

Regulatory T cells (Tregs)

Immune system enhancement

MSCs promote Treg expansion, supporting immune balance rather than immune escalation

Inflammatory cytokines

Immune boost

Well-supported reduction in pro-inflammatory cytokines

Overall effect

“Boosts” immunity

Immunomodulation — calming excessive or dysregulated immune activity

Where Regenerative Medicine Fits In

Clinics offering regenerative and cellular therapies, including R3 Stem Cell, position their protocols around this immunomodulatory and anti-inflammatory profile of MSCs rather than the inaccurate idea of a blanket immune “boost.” For patients researching options related to chronic inflammation or age-related immune changes, the relevant question to ask any provider isn’t whether a therapy will supercharge immunity, but whether there’s evidence it can help rebalance an overactive or chronically inflamed immune system in a way that’s meaningful for their specific health goals. Understanding what matters when choosing a regenerative medicine clinic can help set realistic expectations from the outset.

As with any regenerative therapy, results vary by individual, and patients should seek a thorough consultation to understand what a given protocol can and cannot be reasonably expected to do.

Frequently Asked Questions

Do mesenchymal stem cells cure autoimmune disease?

No. MSCs are being studied as an immunomodulatory approach in autoimmune and inflammatory conditions, but they are not established cures, and outcomes vary across studies and patient populations.

Is it accurate to say MSCs "supercharge" the immune system?

Not based on current evidence. The research more consistently supports an immune-regulating (immunomodulatory) role, with the clearest, most reproducible benefit being a reduction in chronic inflammatory signaling.

This is an active area of research. The connection between MSCs and reduced inflammaging is biologically plausible and supported by cytokine data, but long-term clinical outcome data in otherwise healthy aging adults is still developing.

Contact Us